Pfizer Research and Development Expenses 2012-2026 | PFE

Pfizer research and development expenses for the twelve months ending March 31, 2026 were $10.724B, a 1.82% increase year-over-year.

  • Pfizer annual research and development expenses for 2025 were $10.437B, a 3.56% decline from 2024.
  • Pfizer annual research and development expenses for 2024 were $10.822B, a 1.34% increase from 2023.
  • Pfizer annual research and development expenses for 2023 were $10.679B, a 6.55% decline from 2022.

Pfizer Research and Development Expenses 2012-2026 | PFE

  • Pfizer annual research and development expenses for 2025 were $10.437B, a 3.56% decline from 2024.
  • Pfizer annual research and development expenses for 2024 were $10.822B, a 1.34% increase from 2023.
  • Pfizer annual research and development expenses for 2023 were $10.679B, a 6.55% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B